Large Genome-Wide Association Study Identifies Novel Abdominal Aortic Aneurysm Risk Loci
By LabMedica International staff writers Posted on 05 Oct 2020 |
Image: Illustration of the heart with magnification of the artery (Photo courtesy of American Heart Association)
A recent report identified novel genetic associations for abdominal aortic aneurysm (AAA) with therapeutic implications and identified a subset of the population at significantly increased genetic risk of AAA that was independent of family history.
AAA is a localized enlargement of the abdominal aorta such that the diameter is greater than three centimeters or more than 50% larger than normal. They usually cause no symptoms, except during rupture. Rupture may result in pain in the abdomen or back, low blood pressure, or loss of consciousness, and often results in death. AAAs occur most commonly in men over 50 years old, and among those with a family history. Additional risk factors include smoking, high blood pressure, and other heart or blood vessel diseases. AAAs are the most common form of aortic aneurysm. In the United States, screening with abdominal ultrasound is recommended for males between 65 and 75 years of age with a history of smoking. The genetic determinants of AAA remain incompletely defined. In total, 10 previously identified risk loci explain only a small fraction of the inheritance of AAA.
Investigators at Stanford University (Palo Alto, CA, USA) and a large number of collaborators from other institutions performed a genome-wide association study (GWAS) on samples obtained from the Million Veteran Program. This program, which was initiated in 2011 and is now one of the world's largest genetic biobanks, was designed to promote the study of how genes affect the health of United States military veterans.
For the current study, the investigators performed a GWAS on nearly 18 million DNA sequence variants with AAA (7,642 cases and 172,172 controls) in veterans of European ancestry with independent replication in up to 4,972 cases and 99,858 controls. They then used Mendelian randomization to examine the causal effects of blood pressure on AAA. In addition, they examined the association of AAA risk variants with aneurysms in the lower extremity, cerebral, and iliac arterial beds, and derived a genome-wide polygenic risk score (PRS) to identify a subset of the population at greater risk for the disease.
Results revealed 14 novel genetic loci, bringing the total number of known significant AAA loci to 24. A genetic-linked increase of 10 millimeters of mercury (Hg) in diastolic blood pressure increased the risk of developing abdominal aortic aneurysm. Analysis showed further that 19 of the 24 risk loci for AAA were associated with aneurysms in other parts of the body. A 29-variant PRS was strongly associated with AAA, independent of family history and smoking risk factors. Using this PRS, the investigators identified a subset of the population with AAA prevalence greater than that observed in screening trials performed according to current guidelines.
"This study has doubled the number of genetic associations with abdominal aortic aneurysm, adding greatly to our understanding of the disease mechanisms," said senior author Dr. Philip S. Tsao, professor of cardiovascular medicine at Stanford University. "We were surprised that diastolic blood pressure, as opposed to systolic blood pressure, is likely of greater significance in the development of abdominal aortic aneurysm. This new information can enhance screening protocols and help identify individuals at risk for abdominal aortic aneurysm."
The AAA study was published in the September 28, 2020, online edition of the journal Circulation.
Related Links:
Stanford University
AAA is a localized enlargement of the abdominal aorta such that the diameter is greater than three centimeters or more than 50% larger than normal. They usually cause no symptoms, except during rupture. Rupture may result in pain in the abdomen or back, low blood pressure, or loss of consciousness, and often results in death. AAAs occur most commonly in men over 50 years old, and among those with a family history. Additional risk factors include smoking, high blood pressure, and other heart or blood vessel diseases. AAAs are the most common form of aortic aneurysm. In the United States, screening with abdominal ultrasound is recommended for males between 65 and 75 years of age with a history of smoking. The genetic determinants of AAA remain incompletely defined. In total, 10 previously identified risk loci explain only a small fraction of the inheritance of AAA.
Investigators at Stanford University (Palo Alto, CA, USA) and a large number of collaborators from other institutions performed a genome-wide association study (GWAS) on samples obtained from the Million Veteran Program. This program, which was initiated in 2011 and is now one of the world's largest genetic biobanks, was designed to promote the study of how genes affect the health of United States military veterans.
For the current study, the investigators performed a GWAS on nearly 18 million DNA sequence variants with AAA (7,642 cases and 172,172 controls) in veterans of European ancestry with independent replication in up to 4,972 cases and 99,858 controls. They then used Mendelian randomization to examine the causal effects of blood pressure on AAA. In addition, they examined the association of AAA risk variants with aneurysms in the lower extremity, cerebral, and iliac arterial beds, and derived a genome-wide polygenic risk score (PRS) to identify a subset of the population at greater risk for the disease.
Results revealed 14 novel genetic loci, bringing the total number of known significant AAA loci to 24. A genetic-linked increase of 10 millimeters of mercury (Hg) in diastolic blood pressure increased the risk of developing abdominal aortic aneurysm. Analysis showed further that 19 of the 24 risk loci for AAA were associated with aneurysms in other parts of the body. A 29-variant PRS was strongly associated with AAA, independent of family history and smoking risk factors. Using this PRS, the investigators identified a subset of the population with AAA prevalence greater than that observed in screening trials performed according to current guidelines.
"This study has doubled the number of genetic associations with abdominal aortic aneurysm, adding greatly to our understanding of the disease mechanisms," said senior author Dr. Philip S. Tsao, professor of cardiovascular medicine at Stanford University. "We were surprised that diastolic blood pressure, as opposed to systolic blood pressure, is likely of greater significance in the development of abdominal aortic aneurysm. This new information can enhance screening protocols and help identify individuals at risk for abdominal aortic aneurysm."
The AAA study was published in the September 28, 2020, online edition of the journal Circulation.
Related Links:
Stanford University
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans